Title:
METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROSIS
Document Type and Number:
WIPO Patent Application WO/2024/078628
Kind Code:
A1
Abstract:
Provided is a method for treating osteoporosis, and further provided is a drug for treating osteoporosis, comprising: a therapeutically effective amount of ONT-380 or a pharmaceutically acceptable salt thereof, or a combination of ONT-380 or a pharmaceutically acceptable salt thereof with one of the following compounds: NVP-BHG712, AMG-900, KD025, or a pharmaceutically acceptable salt thereof.
Inventors:
ZHAO YUERAN (CN)
CHEN ZIJIANG (CN)
NING YUNNA (CN)
MA JINLONG (CN)
CAO YONGZHI (CN)
LU GANG (CN)
CHEN ZIJIANG (CN)
NING YUNNA (CN)
MA JINLONG (CN)
CAO YONGZHI (CN)
LU GANG (CN)
Application Number:
PCT/CN2023/124591
Publication Date:
April 18, 2024
Filing Date:
October 13, 2023
Export Citation:
Assignee:
UNIV SHANDONG (CN)
International Classes:
A61K31/519; A61P19/10; C07D471/04
Domestic Patent References:
| WO2021194396A1 | 2021-09-30 |
Foreign References:
| CN113613656A | 2021-11-05 | |||
| US20160317518A1 | 2016-11-03 | |||
| CN105120869A | 2015-12-02 | |||
| US20200390736A1 | 2020-12-17 |
Other References:
MURTHY, R.K. ET AL.: "Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 382, no. 7, 13 February 2020 (2020-02-13), XP055768473, DOI: 10.1056/NEJMoa1914609
Attorney, Agent or Firm:
SPREADWINGS INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: